StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > No sellers under 0.30

<< Previous

Bullboard Posts

Next >>

Comment by IainCaimbeulon Jan 17, 2022 3:54pm

100 Views

Post# 34325841

RE:No sellers under 0.30

You think it is a conspiracy? Guffaw guffaw guffaw. This pig will be stuck until at least end of March unless there ia some outstanding news which based on past performance is highly unlikely.

Now, cue mykndsrn for some sort of banal snotty remark.

LithLover wrote: Are we to beleive there are no sellers at 0.275 or 0.285 but yet identical amounts for sale at 0.28 and 0.29. Sure OK.

Level two quotes - Ask

Ask Price Number of Shares

0.280 9,000

9,000 shares

0.290 9,000